Skip to main content

Advertisement

Log in

Anti-N-methyl-d-aspartate receptor encephalitis with lung adenocarcinoma

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDAR-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dalmau J, Lancester E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13(2):167–177

    Article  CAS  PubMed  Google Scholar 

  4. Armangue T, Titulaer MJ, Sabater L et al (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75(3):435–441

    Article  PubMed  Google Scholar 

  5. North WG, Gao G, Jensen A et al (2010) NMDA receptors are expressed by small-cell lung cancer are potential targets for effective treatment. Chin Pharmacol 2:31–40

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie-Wen Zhang.

Ethics declarations

Conflict of interest

All authors have no conflict of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, YY., He, XJ., Zhang, ML. et al. Anti-N-methyl-d-aspartate receptor encephalitis with lung adenocarcinoma. Neurol Sci 37, 1573–1575 (2016). https://doi.org/10.1007/s10072-016-2563-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2563-4

Keywords

Navigation